Jay Bradner is a doctor at Amgen.
3 reports, 1 independent
Updated Aug 12
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jay Bradner is a doctor at Amgen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jay Bradner has been identified as a doctor at Amgen since August 12, 2025.1 source
- Jay Bradner's role at Amgen is detailed alongside Zai Lab's commercialization rights in Macau and China.
Keep exploring
The entities involved
-
Jay Bradner
research scientist at Harvard and Dana Farber
Nothing else this week.
-
Amgen
American multinational biopharmaceutical company
Coverage
Newest first; wire copies grouped- Insider MonkeyAmgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN)
- Unknown outlet
- Unknown outlet